Alvotech
ALVOW
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$0.33
FAIR PRICE
$0.49
MARGIN
$0.16
COMING SOON
Get notified when ALVOW's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
Vilhelm Robert Wessman
COUNTRY
IS
HEADQUARTERS
Luxembourg
SECTOR
Healthcare
EXCHANGE
NASDAQ
METHODOLOGY
How we calculate ALVOW's fair price
Alvotech's fair price of $0.49 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $0.33, ALVOW trades 48.4% below its calculated fair value.
DCF MODEL · 50%
Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting ALVOW's risk profile.
RELATIVE · 30%
Comparing ALVOW's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.
ANALYST · 20%
Aggregated analyst price targets for ALVOW, weighted by recency and analyst accuracy.
TRY IT YOURSELF
Want to test your own assumptions? Use our free calculators to estimate ALVOW's fair value with your own inputs.
LEARN MORE
POWERED BY BULIOS
Get full analysis, financials, and AI insights for ALVOW.
Explore on BuliosFAQ
What is the fair price of ALVOW?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Alvotech is $0.49. At the current market price of $0.33, ALVOW trades 48.4% below its calculated fair value.
Is ALVOW overvalued or undervalued?+
Alvotech is currently undervalued based on our valuation model. The stock trades at $0.33, which is 48.4% below the fair price of $0.49. The P/E ratio of 127.0x is a key metric in the valuation.
How often is ALVOW's fair price updated?+
We update fair price calculations for ALVOW daily after market close. The current fair price of $0.49 incorporates the latest market data and sector multiples.
What factors affect ALVOW's fair price calculation?+
ALVOW's fair price of $0.49 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight). Key metrics include P/E of 127.0x, ROE of -11.9%.
Is ALVOW a good buy right now?+
At $0.33, ALVOW trades 48.4% below our fair value estimate of $0.49. The stock is currently undervalued. ROE stands at -11.9% (average). Fair Price Index provides valuation data — always do your own research before investing.
Does ALVOW pay dividends?+
ALVOW does not currently pay a dividend.
RELATED STOCKS
Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.